Metagenomi Q3 EPS $(0.55) Beats $(0.60) Estimate, Sales $8.659M Beat $7.400M Estimate
Metagenomi (NASDAQ:MGX) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.60) by 7.87 percent. This is a 7.84 percent decrease over losses of $(0.51) per share from the same
